Thirteenth Annual Steven M. Podos, MD Symposium and Lecture: Innovations in Ophthalmology

Friday, June 7, 2024, 7:45 AM - 4:30 PM, The New York Academy of Medicine, New York, NY


This live and onsite activity is designed to provide participants with an update on a variety of topics related to innovations in the fields of Cornea, Glaucoma, Neuro-ophthalmology, Oculoplastics, Pediatric Ophthalmology, Retina, and Oncology. There will be a special focus on approaches to providing eye care to the pediatric population.

1. Demonstrate current diagnosis and management strategies for patients with glaucoma and corneal disease.
2. Discuss emerging technologies in the surgical management of cataract and glaucoma.
3. Compare current approaches to the management of thyroid eye disease, orbital tumors, and retinoblastoma.
4. Recognize the use of new imaging modalities in the study and management of uveitis and vitreo-retinal disorders

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (7.00 hours), Non-Physician Attendance (7.00 hours)

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

Icahn School of Medicine at Mount Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, June 7, 2024